News – Page 1096 – Endpoints News

Big Pharma veterans at Pfizer, AstraZeneca join the great migration to biotech

8 years ago

Post-merger, Indalo raises $9M; Spark raising $331M; No word on Shkreli’s fate

8 years ago

Aeterna Zentaris claims it booted CEO and then discovered a plot to grab control of its lead asset

8 years ago

Eli Lilly’s new, $1B pain drug racks up another promising round of PhIII pain data

8 years ago

Look out Gilead, AbbVie’s hep C combo comes with stellar data, 8-week regimen and a killer price

8 years ago

Dynavax shares dip after FDA asks for more time to sort out Heplisav post-marketing plan

8 years ago

Trump will sign FDA user fee reauthorization bill, ending threat of agency layoffs

8 years ago

Bristol-Myers beefs up big cancer drug pipeline, buying IFM drugs in $2.3B-plus deal

8 years ago

10 years and $100M-plus later, GSK shutters a China R&D site during a major pipeline overhaul

8 years ago

Teva talks tough on cuts; Takeda bolsters startup with a dedicated cardio discovery team

8 years ago

Sanofi shifts focus to internal R&D as it preps an end to a stunningly effective Regeneron alliance

8 years ago

FDA offers another speedy cancer drug OK, approving Jazz’s Vyxeos for acute myeloid leukemia

8 years ago

Top FDA official accused CDER chief Woodcock of appearing biased, browbeating reviewers in demanding eteplirsen OK

8 years ago

Top Novartis manufacturing exec jumps ship, takes charge of industrializing Moderna’s mRNA tech

8 years ago

Shire plots an ADHD public spinoff as CEO Ornskov completes a top-to-bottom overhaul

8 years ago

FDA experts turn thumbs down on J&J’s troubled rheumatoid arthritis drug sirukumab

8 years ago

After a $200M financing, Highland Therapeutics falls silent on ADHD drug’s fate as PDUFA sails by

8 years ago

Ocular cuts staff in wake of FDA slapdown; Biogen recruits Pfizer vet; X4 inks discovery deal with Yale

8 years ago

Clementia keeps the biotech IPO party going with $120M play on an upsized offering

8 years ago

Running out of cash and kicked out of its HQ by the landlord, PixarBio hunkers down and slashes staff

8 years ago

Spark Therapeutics offers a glimpse of efficacy in first two hemophilia A gene therapy patients

8 years ago

Following PhIII breakdown, AstraZeneca cruises toward an FDA decision for its BTK blockbuster hopeful acalabrutinib

8 years ago

Amplyx grabs $67M to fund a pivotal drive to the FDA with an anti-fungal aimed at a lethal threat

8 years ago

Updated: Celgene, Agios win a landmark FDA OK for new AML drug Idhifa

8 years ago

First page Previous page 1093 1094 109510961097 1098 1099 Next page Last page